Looking at Tickerrisk (https://tickerrisk.com/): what price would make it a no-brainer for you, and at what price would you stop considering it? What would you expect to get for that money? Also say the maximum you would pay per month in USD (0 if nothing).

Page reviewed

TickerRisk — Hidden Risk Scanner for Options Traders

https://tickerrisk.com/ (opens in a new tab)
Saved screenshot of TickerRisk — Hidden Risk Scanner for Options Traders
Screenshot saved with this question. The live page may have changed.Open full image ↗

10 fictional AI personas. Exploratory perspectives, not a survey of real customers. Methodology & limitations

Simulated interest

62/100

AI synthesis, not measured demand

Suggested price range

$20–200

Median $40 · simulated willingness to pay

Response sentiment

Positive 30%Neutral 70%Negative 0%
The takeaway

What this panel suggests

The batch shows moderate interest in TickerRisk: buyers see value in automating the tedious pre-trade checks around earnings, SEC/legal filings, clinical catalysts, and IV signals. The main friction is pricing clarity, not a hard rejection. Several respondents said they could not judge the offer well because the pricing was not clearly laid out, and they wanted explicit tiers and feature breakdowns. The product page text itself shows a free trial and an Upgrade path, but no obvious monthly prices in the extracted content, which may be contributing to that uncertainty. On willingness to pay, the supplied aggregate data points to a low of $20, a median of $40, and a high of $200 per month. A common no-brainer zone appears to be roughly $20-$30/month, especially if the tool reliably flags risks traders might miss and saves manual research time. Expectations for that money are straightforward: comprehensive S&P 500 coverage, trustworthy alerts, and enough accuracy/confidence to prevent avoidable options trades.

A hypothesis to test

Pricing & positioning

A starter price around $20-$30/month looks closest to a no-brainer for the most price-sensitive prospects in this batch. Around $40/month sits near the reported median maximum willingness to pay. Pricing above that would need to be justified by clearly visible value: reliable alerts, comprehensive S&P 500 coverage, and confidence that hidden earnings/legal/clinical/SEC risks are being caught before a trade.

The biggest friction is not outright rejection but uncertainty: respondents wanted explicit tiers and feature breakdowns. The provided page text highlights a free trial and an Upgrade path, but the visible pricing is not explicit enough for some buyers to evaluate. Some buyers would pay much more only if the product consistently saves research time and surfaces risks they would otherwise miss.

Recurring themes

Automation of manual research
“Given my current process of manually checking these, automating some of that could be efficient.”Read Johnathan Treutel’s response →
Pricing transparency and tier clarity
“However, the pricing isn't clearly laid out on the page, so I'd need to see specific tiers and features before committing.”Read Johnathan Treutel’s response →
Need for trustworthy, comprehensive risk data
“Ideally, I'd need to see how comprehensive and accurate the data is before committing.”Read Kelli Ledner’s response →

Objections to investigate

  • Unclear pricing structure
  • High cost relative to free alternatives

Use these findings to plan customer interviews or experiments. How to interpret AI research

What the panel said

Click a name to open that persona’s full profile.

Johnathan Treutelneutral

This tool looks interesting, especially the ability to scan for earnings, filings, and IV signals. Given my current process of manually checking these, automating some of that could be efficient. The 'no-brainer' price would depend on the breadth of coverage and the depth of the data provided, particularly for the market scanner covering the full S&P 500. If it integrates well with my existing spreadsheet workflows and reliably identifies risks I might otherwise miss, I could see paying around $30-$50 per month. However, the pricing isn't clearly laid out on the page, so I'd need to see specific tiers and features before committing. I'd stop considering it if it exceeded $100 per month or if the data proved to be less comprehensive than my current manual checks.

Simulated interest: 60/100

Kelli Lednerneutral

This tool seems to automate some of the tedious cross-referencing I currently do. The ability to scan for earnings, legal, and SEC filings in one place would save significant time. Ideally, I'd need to see how comprehensive and accurate the data is before committing. If it reliably flags risks I might miss, a 'no-brainer' price would be around $25 per month. Anything over $50 per month would make me reconsider its value compared to my manual efforts and other tools.

Simulated interest: 75/100

Krishna Deshpandepositive

For Tickerrisk, a "no-brainer" price would be around $10-$15 per month. At that price, I'd expect comprehensive, real-time data on earnings, SEC filings, and FDA news for all S&P 500 constituents, seamlessly integrated into a watchlist. The "stop considering" price would be anything above $50 per month, as the time commitment for manual research is significant and I'd need to see a clear ROI beyond what I can currently gather myself. I'm currently spending hours each evening manually compiling this data, so a tool that truly automates and enhances this process for less than what I might spend on a few premium options trades would be very compelling. My maximum would be $25 per month, given my focus on selling weekly options which is a high-frequency activity.

Simulated interest: 70/100

Lenn Pietschneutral

For Tickerrisk, I'd consider it "no-brainer" if it were around $20 per month. Anything north of $50 per month would make me pause significantly. For that price, I would expect comprehensive, real-time data on earnings dates, SEC filings, and crucial volatility signals across a broad universe of US equities, easily integrated into my workflow. The free trial is a reasonable starting point, but I'd need to see the full Pro offering's value proposition before committing further. My maximum would be $20 per month.

Simulated interest: 60/100

Vera Trantowneutral

This looks like a useful tool for quickly scanning for risks before earnings or other catalysts. The ability to see SEC filings, legal news, and IV signals in one place is valuable. For a "no-brainer" price, I'd consider it if it were around $20-$30 per month. I'd stop considering it if it went over $75 per month, as my own research process, while time-consuming, often covers these bases already. I expect a comprehensive dataset, customizable alerts, and perhaps some analytical tools to interpret the risk scores.

Simulated interest: 60/100

Tommie Schulistneutral

Well, I tend to be quite frugal, as you know. I currently manage to get all the information I need from free resources, so paying for a service like Tickerrisk would have to offer a substantial benefit. If it could reliably flag hidden risks that I might otherwise miss, and perhaps streamline my research significantly, I might consider a price around $15 to $20 per month. Anything above $30 would likely be a non-starter for me, especially as I only trade part-time from a retirement account. It's difficult to say precisely what I'd expect, but I'd hope for highly accurate, actionable insights that directly save me time or prevent a costly error.

Simulated interest: 40/100

Longin Rouxneutral

This Tickerrisk platform appears to provide useful data for identifying event risk, which is a significant part of my work. The "hidden catalysts" scan for earnings, legal, and FDA alerts, especially when integrated across the S&P 500, could be valuable. However, the pricing details are not clearly presented on this page. I would need to see a clear breakdown of features included at different tiers and their associated costs. Without that transparency, it's difficult to assign a definitive price. Ideally, for comprehensive S&P 500 coverage and advanced screening capabilities, I might consider paying up to $200 per month if it demonstrably improved our risk assessment efficiency and reduced unforeseen losses.

Simulated interest: 50/100

Maurice Kertzmannneutral

This Tickerrisk tool sounds interesting for scanning risks, which is precisely what I do manually now. The "Pro" tier is mentioned, but I don't see any explicit pricing for it, only a "14-Day Pro Trial." Without clear pricing, it's impossible to determine a "no-brainer" price or a point where I'd stop considering it. I'd expect to get a consolidated view of earnings, legal, and SEC filings across the S&P 500 for the monthly fee. My maximum acceptable price would be $50 per month, but that's contingent on seeing the full feature set and value proposition.

Simulated interest: 50/100

Sucheta Jangidpositive

The concept of scanning for hidden catalysts is precisely what I need for managing risk in my options selling strategy. I'm already meticulously tracking earnings and filings, so automating that and getting a risk score would be immensely valuable. For a no-brainer price, I'd be looking around $20-30 per month. If it exceeded $50 per month, I'd have to seriously reconsider, especially given I'm self-employed and operate frugally. I'd expect comprehensive data and reliable alerts that genuinely help me avoid unexpected market moves, justifying the cost.

Simulated interest: 75/100

Marion Boylepositive

This Tickerrisk tool looks promising for flagging hidden catalysts, which is exactly the kind of diligence I put into my hedging sleeve. The idea of automating some of that risk assessment is appealing. If it consistently provided high-quality, actionable insights that saved me time compared to my current manual review of filings and IV moves, I'd consider it. A 'no-brainer' price for me would be around $75 per month, assuming it covers scanning a broad universe of stocks and provides detailed alerts. I'd stop considering it if it were over $150 per month, as that starts to eat into the yield generated by my strategies.

Simulated interest: 75/100

Keep exploring.

Find your next question or see which topics divide AI panels.

Keep exploring

What would you ask next?

Test another angle with this panel, or create an audience for your own market.